- Added to Email Alerts
Moderate to Severe Asthma
Latest News View All
-
Fasenra Approved in Europe for Rare Blood Vessel Disorder
-
ERS 2024Asthma Remission and EGPA With Biologics
-
GSK's Asthma Drug Nucala Meets Main Goal in Study on Treating Smoker's Lungs
-
Children With Medicaid Receive Less Specialty Asthma Care
-
Asthma Treatment During Pregnancy: Stay the Course!
-
Can Chemical Agents and Pollens Induce Food Allergies?
-
The Primary Care Show 2024Asthma: Reduce Reliance on the Blue Inhaler
-
ATS 2024Biologics Improve Outcomes in Patients With COPD, Asthma
Perspective View All
Journal Articles View All
-
New Approaches in Childhood Asthma Treatment
-
Effectiveness of mRNA Vaccines Among Children Aged 3-5 Years
-
Peripheral Blood Eosinophilia and Asthma Severity
-
Bivalent Booster Effectiveness Against New SARS-CoV-2 Variants
-
The Influence of COVID-19 Disease on Asthma
-
Experience of Super-Responders to Biologics in Severe Asthma